Rare Disease Report

Fitusiran and Hemophilia: Early Data Very Promising

JANUARY 06, 2017
Pushkal Garg, MD



Pushkal Garg, MD, of Alnylam Pharmaceuticals discusses the recent data on the efficacy and safety of fitusiran to treat patients with hemophilia. 
 
The data discussed was presented at the  ASH Annual Meeting & Exposition recently held in San Diego, CA.


To stay informed on the latest in rare disease news and developments, please sign up for our weekly newsletter at www.raredr.com/newsletter


Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.